Positive News SentimentPositive NewsNASDAQ:STTK Shattuck Labs (STTK) Stock Price, News & Analysis $0.85 -0.02 (-2.63%) Closing price 04:00 PM EasternExtended Trading$0.85 0.00 (-0.02%) As of 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Shattuck Labs Stock (NASDAQ:STTK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Shattuck Labs alerts:Sign Up Key Stats Today's Range$0.83▼$0.9050-Day Range$0.75▼$1.1952-Week Range$0.69▼$4.59Volume114,817 shsAverage Volume501,071 shsMarket Capitalization$40.53 millionP/E RatioN/ADividend YieldN/APrice Target$7.50Consensus RatingModerate Buy Company Overview Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas. Read More Shattuck Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreSTTK MarketRank™: Shattuck Labs scored higher than 73% of companies evaluated by MarketBeat, and ranked 289th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingShattuck Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageShattuck Labs has received no research coverage in the past 90 days.Read more about Shattuck Labs' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Shattuck Labs are expected to grow in the coming year, from ($1.48) to ($0.83) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shattuck Labs is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Shattuck Labs is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioShattuck Labs has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Shattuck Labs' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.85% of the float of Shattuck Labs has been sold short.Short Interest Ratio / Days to CoverShattuck Labs has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shattuck Labs has recently decreased by 51.92%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldShattuck Labs does not currently pay a dividend.Dividend GrowthShattuck Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.85% of the float of Shattuck Labs has been sold short.Short Interest Ratio / Days to CoverShattuck Labs has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shattuck Labs has recently decreased by 51.92%, indicating that investor sentiment is improving significantly. News and Social Media3.3 / 5News SentimentN/A News SentimentShattuck Labs has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.06 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Shattuck Labs this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for STTK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Shattuck Labs to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Shattuck Labs insiders have not sold or bought any company stock.Percentage Held by Insiders12.00% of the stock of Shattuck Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions58.74% of the stock of Shattuck Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Shattuck Labs' insider trading history. Receive STTK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shattuck Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address STTK Stock News HeadlinesShattuck Labs (NASDAQ:STTK) Shares Down 2% - Here's What HappenedJuly 17, 2025 | americanbankingnews.comShattuck Labs Elects Directors, Approves Auditor at MeetingJuly 15, 2025 | tipranks.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.July 25 at 2:00 AM | Timothy Sykes (Ad)Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and MetabolismJuly 2, 2025 | globenewswire.comShattuck Labs, Inc. (STTK) - Yahoo FinanceJune 28, 2025 | finance.yahoo.comHere's Why We're Watching Shattuck Labs' (NASDAQ:STTK) Cash Burn SituationJune 13, 2025 | finance.yahoo.comShattuck Labs Advances SL-325 Program Amid Financial ProgressMay 5, 2025 | tipranks.comShattuck Labs Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 1, 2025 | globenewswire.comSee More Headlines STTK Stock Analysis - Frequently Asked Questions How have STTK shares performed this year? Shattuck Labs' stock was trading at $1.21 at the beginning of the year. Since then, STTK stock has decreased by 30.1% and is now trading at $0.8462. How were Shattuck Labs' earnings last quarter? Shattuck Labs, Inc. (NASDAQ:STTK) released its quarterly earnings results on Thursday, May, 1st. The company reported ($0.27) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.02. When did Shattuck Labs IPO? Shattuck Labs (STTK) raised $150 million in an IPO on Friday, October 9th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and Evercore ISI served as the underwriters for the IPO and Needham & Co. was co-manager. How do I buy shares of Shattuck Labs? Shares of STTK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Shattuck Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shattuck Labs investors own include Invesco QQQ (QQQ), SPDR Dow Jones Industrial Average ETF Trust (DIA), SPDR S&P 500 ETF Trust (SPY), Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA) and Advanced Micro Devices (AMD). Company Calendar Last Earnings5/01/2025Today7/25/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:STTK CIK1680367 Webwww.shattucklabs.com Phone512-900-4690FaxN/AEmployees100Year FoundedN/APrice Target and Rating Average Price Target for Shattuck Labs$7.50 High Price Target$16.00 Low Price Target$2.00 Potential Upside/Downside+786.3%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($1.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$75.41 million Net MarginsN/A Pretax Margin-1,532.96% Return on Equity-79.69% Return on Assets-69.13% Debt Debt-to-Equity RatioN/A Current Ratio9.08 Quick Ratio9.08 Sales & Book Value Annual Sales$5.72 million Price / Sales7.09 Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book0.51Miscellaneous Outstanding Shares47,900,000Free Float42,155,000Market Cap$40.53 million OptionableOptionable Beta1.63 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:STTK) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shattuck Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.